Pfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve This is to inform that a meeting of ....
PFIZER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pfizer Ltd has informed the stock exchanges that its Board of Directors will meet on Wednesday, November 12, 2025 to consider, approve and take on record the Unaudited Financial Results for the quarter and half year ended September 30, 2025 (i.e., Q2 FY26 and H1 FY26 results). The intimation has been filed under Regulation 29 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The company's trading window for dealing in shares has been closed from the close of business on September 30, 2025 and will remain closed until 48 hours after the results are made public on November 12, 2025. This is a routine compliance filing ahead of the earnings announcement and does not contain any financial figures or projections.
This is a routine pre-results intimation with no immediate impact on the stock price. Investors should watch the November 12, 2025 results for actual revenue, profit and margin trends, which will be the real catalyst for any stock movement.